West Pharmaceutical Services Resultados de beneficios anteriores
Pasado controles de criterios 5/6
West Pharmaceutical Services ha aumentado sus beneficios a una tasa media anual de 19.7%, mientras que los beneficios de la industria de Life Sciences han experimentado un crecimiento de 16.4% anual. Los ingresos han ido creciendo a una tasa media de 12% al año. La rentabilidad financiera de West Pharmaceutical Services es de 19.7%, y sus márgenes netos son de 19.4%.
Información clave
19.7%
Tasa de crecimiento de los beneficios
19.6%
Tasa de crecimiento del BPA
Crecimiento de la industria Life Sciences | 21.5% |
Tasa de crecimiento de los ingresos | 12.0% |
Rentabilidad financiera | 21.2% |
Margen neto | 19.4% |
Última actualización de beneficios | 31 Mar 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price
Mar 30Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?
Mar 12Why West Pharma Is Far From Done
Feb 28West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price
Feb 20West Pharmaceutical Services: Still Too Expensive After The Recent Drop
Feb 20What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?
Jan 10West Pharmaceutical: Great Business, Not So Great Valuation
Jan 08What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You
Dec 18West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Nov 27West Pharmaceutical Services: The Run Might Be Over
Oct 18Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?
Sep 24Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
Aug 22West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics
Aug 08What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?
Jun 26West Pharmaceutical: Hard To Justify The Price
May 26Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
May 16At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?
Mar 20West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture
Feb 28West Pharmaceutical Q4 2022 Earnings Preview
Feb 15West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Jan 31West Pharmaceutical: An Earnings Decline Seen In 2023, Shares Still Appear Expensive
Dec 19West Pharmaceutical declares $0.19 dividend
Dec 13Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching
Nov 29West Pharmaceutical Q3 2022 Earnings Preview
Oct 26West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly
Oct 25West Pharmaceutical Services: Shares Need To Get Cheaper To Make Sense
Oct 02Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 14Is There Now An Opportunity In West Pharmaceutical Services, Inc. (NYSE:WST)?
Aug 31Do West Pharmaceutical Services' (NYSE:WST) Earnings Warrant Your Attention?
Aug 18West Pharmaceutical Q2 Non-GAAP EPS, revenue beats
Jul 28Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
Jul 27West Pharmaceutical Services: A Great Business At A Lofty Price
Jul 06West Pharmaceutical Services, Inc. (NYSE:WST) Shares Could Be 32% Above Their Intrinsic Value Estimate
Jun 09Should You Think About Buying West Pharmaceutical Services, Inc. (NYSE:WST) Now?
May 20Does West Pharmaceutical Services (NYSE:WST) Deserve A Spot On Your Watchlist?
May 05Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero West Pharmaceutical Services. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Mar 24 | 2,929 | 569 | 355 | 69 |
31 Dec 23 | 2,950 | 593 | 354 | 68 |
30 Sep 23 | 2,927 | 559 | 299 | 66 |
30 Jun 23 | 2,866 | 519 | 326 | 63 |
31 Mar 23 | 2,884 | 552 | 319 | 61 |
31 Dec 22 | 2,887 | 586 | 316 | 59 |
30 Sep 22 | 2,909 | 631 | 377 | 56 |
30 Jun 22 | 2,929 | 686 | 352 | 56 |
31 Mar 22 | 2,881 | 684 | 362 | 55 |
31 Dec 21 | 2,832 | 662 | 356 | 53 |
30 Sep 21 | 2,681 | 613 | 340 | 52 |
30 Jun 21 | 2,523 | 519 | 310 | 51 |
31 Mar 21 | 2,326 | 423 | 308 | 48 |
31 Dec 20 | 2,147 | 346 | 301 | 47 |
30 Sep 20 | 2,037 | 312 | 291 | 44 |
30 Jun 20 | 1,945 | 286 | 297 | 41 |
31 Mar 20 | 1,888 | 261 | 277 | 40 |
31 Dec 19 | 1,840 | 242 | 273 | 39 |
30 Sep 19 | 1,792 | 230 | 262 | 39 |
30 Jun 19 | 1,767 | 229 | 259 | 39 |
31 Mar 19 | 1,745 | 219 | 258 | 41 |
31 Dec 18 | 1,717 | 207 | 256 | 40 |
30 Sep 18 | 1,711 | 155 | 257 | 40 |
30 Jun 18 | 1,677 | 151 | 256 | 39 |
31 Mar 18 | 1,627 | 133 | 248 | 38 |
31 Dec 17 | 1,599 | 151 | 243 | 39 |
30 Sep 17 | 1,566 | 190 | 245 | 39 |
30 Jun 17 | 1,544 | 176 | 242 | 39 |
31 Mar 17 | 1,535 | 182 | 243 | 38 |
31 Dec 16 | 1,509 | 144 | 238 | 37 |
30 Sep 16 | 1,487 | 138 | 241 | 37 |
30 Jun 16 | 1,454 | 102 | 238 | 37 |
31 Mar 16 | 1,426 | 85 | 246 | 36 |
31 Dec 15 | 1,400 | 96 | 243 | 34 |
30 Sep 15 | 1,390 | 94 | 240 | 32 |
30 Jun 15 | 1,401 | 123 | 241 | 33 |
31 Mar 15 | 1,411 | 133 | 228 | 35 |
31 Dec 14 | 1,421 | 127 | 229 | 37 |
30 Sep 14 | 1,414 | 119 | 230 | 39 |
30 Jun 14 | 1,400 | 115 | 230 | 39 |
31 Mar 14 | 1,376 | 108 | 232 | 39 |
31 Dec 13 | 1,368 | 112 | 235 | 38 |
30 Sep 13 | 1,347 | 110 | 234 | 37 |
30 Jun 13 | 1,309 | 98 | 231 | 35 |
Ingresos de calidad: WST tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (19.4%) de WST son superiores a los del año pasado (19.1%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de WST han crecido un 19.7% al año en los últimos 5 años.
Acelerando crecimiento: El crecimiento de los beneficios de WST en el último año (3%) está por debajo de su media de 5 años (19.7% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de WST en el último año (3%) superó al de la industria Life Sciences -6.6%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera (21.2%) de WST se considera alta.